首页> 外文期刊>Oie Bulletin >Development of vaccines against peste des petits ruminants: CIRAD’s achievements and future challenges
【24h】

Development of vaccines against peste des petits ruminants: CIRAD’s achievements and future challenges

机译:研制抗小反刍兽疫疫苗:CIRAD的成就和未来挑战

获取原文
           

摘要

Summary CIRAD, France, in collaboration with the Pirbright Institute, United Kingdom, was the ?rst laboratory to develop a live attenuated vaccine against peste des petits ruminants (PPR). This vaccine available in the 1980s was shown to provide a life-long immunity after a single injection [5] and is now widely used in sheep and goats. New vaccines are in development, more speci?cally thermotolerant vaccines for use in tropical conditions and DIVA (differentiating infected from vaccinated animals) vaccines to gain virus-free status more easily and rapidly. This paper reviews most of the current and recently developed vaccines at CIRAD and emphasises their adequate delivery and utilisation in the ?eld, for successfully decreasing the incidence of PPR.
机译:总结法国CIRAD与英国Pirbright研究所合作,是第一个开发针对小反刍动物(PPR)的减毒活疫苗的实验室。在1980年代,这种疫苗被证明可提供单次注射后的终身免疫[5],目前已广泛用于绵羊和山羊。正在开发新的疫苗,特别是在热带条件下使用的耐热疫苗和DIVA(与接种疫苗的动物区别感染)疫苗,以更轻松,更快速地获得无病毒状态。本文回顾了CIRAD的大多数当前和最近开发的疫苗,并强调了它们在生产领域的充分交付和利用,以成功降低PPR的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号